Sunday, November 1, 2026

Altria: Dutiful

Altria raised 2026 adjusted EPS guidance to $5.66 to $5.74 and authorized more buybacks, while on! loses share as cigarette margins hold.

MO $130B

Invariant 31h ago 1 click

31h ago CRWD $267B

Sleep Well Portfolio (Oct 2026) - SWI#25 and #26 Adding Exposure to AI.

Sleep Well Investments 6 clicks

36h ago TGOPF $32B

Portfolio Update October 2026

D Invests 3 clicks

From X

@TidefallCapital Oct 30

Trevor Scott on X

I was wrong. I didn't love the $AAPL Duo! Without an apple watch you have to use the touchID which is difficult, apps not optimized, the outer screen is small and after two decades of muscle memory, it's hard to shift. Also cases don't attach well so it feels delicate. Returning!

@ChrisCamillo Oct 30

Chris Camillo on X

I love leverage but this is a dangerous market to overplay your hand on short term trades. Added aggressively to $AMZN last night while deleveraging everywhere else. The risk of further fear driven volatility is too high whether justified or not. This is a time to think like a long term investor and not let short term leverage take you out of the game.

@John_Hempton Oct 30

John_Hempton on X

@RawBooty2 yep. we are doing slightly better... biggest long is $REGN

@valuedontlie Oct 30

Colin King on X

$TFC CEO with another sizable insider buy… New CEO, first bout of insider buying in years, discount to bank peers, etc. Seems interesting… https://t.co/TAuHtUOU3K

@ChrisCamillo Oct 30

Chris Camillo on X

@Gregtrendspot Discussed $RDDT on yesterday’s @DumbMoneyTV. AI queries are a massive headwind to traffic growth. Reddit’s future valuation may hinge less on user growth and more on its ability to renegotiate licensing deals with frontier AI labs to get paid big for the content they pull.

@kab604 Oct 30

kab60 on X

$GPN might get taken out by CDR+GTRC... 5xFCF, ~MSD growth, expanding margins... Who would've thought

@leevalueroach Oct 30

Lee Roach on X

At some point I might need to take my balls out of my trousers and place them on the $RDDT table. Looks overblown. https://t.co/ACZtt9mj59

@convequity Oct 30

Convequity on X

Buying an inference provider could make a software company's AI growth look much stronger. I partly agree with Sridhar. Ali Ghodsi's strengths extend well beyond technology into marketing, dealmaking and fundraising. I see Databricks as a very aggressive commercial operator, and staying private gives it more flexibility over which financial metrics the public gets to scrutinize. Snowflake ($SNOW) has to defend its growth alongside margins, stock-based compensation and dilution every quarter. Databricks has more room to prioritize the growth number in its public messaging while making trade-offs elsewhere. I'd like to see their full financials side by side. Separate core platform growth from inference resale, identify how much comes from AI-native customers, and quantify any benefit from changes in billing. Then compare gross profit, cash flow and dilution on the same basis. Inference is especially interesting here. A provider can collect a large customer bill while paying much of it to model or compute suppliers. Where accounting rules allow that full bill to be recognized as revenue, the business can add a lot of AI revenue for relatively little gross profit. That could make inference companies attractive acquisition targets for software vendors under pressure to show AI growth. Baseten and Fireworks come to mind, along with RadixArk and Inferact, founded by the creators of SGLang and vLLM respectively. These businesses offer serving technology and customers. An acquisition could also immediately increase the buyer's reported AI revenue, with a much smaller contribution to earnings if the acquired business has thin margins. The revenue boost would be acquired growth, so organic growth needs to remain visible. I wouldn't be surprised to see Snowflake and other publicly traded companies explore this route. If investors reward the added AI revenue more than the underlying gross profit warrants, buyers have an incentive to pay very high prices for these businesses.

Agnico Eagle: Soaring Above The Peer Group

Agnico Eagle expects low-end 2026 guidance despite Barnat setbacks, while Hope Bay, Upper Beaver and Odyssey support production above 4…

AEM $92B

Taylor Dart 36h ago 3 clicks

Amazon.com Inc (AMZN) Earnings Update: Q3 2026

Amazon reported Q3 2026 net sales up 12% year over year to $201.9 billion, narrowly below the $202.3 billion consensus estimate.

AMZN $2.6T

SixSigmaCapital: Navigating the Financial Markets 47h ago 7 clicks

Expert Call | Optical Module Ramps, Lumentum vs. Coherent Momentum, Server CPU, and Advanced Packaging Constraints

AAOI, Lumentum and Coherent 800G ramps, NVIDIA Rubin timing, and AMD, Intel and Arm server CPU demand frame an expert call on AI…

LITE $83BCOHR $47B

P Equity Research Oct 31 1 click

FTAI 3Q26: Aero margins in focus

FTAI’s Aerospace Products margin rebounded to 31% as CFM56 module output rose, while Power deposits and contracted deliveries fund its 2027…

FTAI $16B

Stock Thoughts Oct 31 4 clicks

Anthropic’s Growth is Slowing: Is AI Capex Next? | The Weekly Wrap

Anthropic’s revenue growth slowed from 147% in Q2 to 45% in Q3, raising questions about AI capital spending as Amazon holds capex flat.

AMZN $2.6T

Steve Eisman Oct 30 5 clicks

American Tower's Starlink Opportunity

American Tower could gain $1.13 to $3.54 in AFFO per share if Starlink accesses 80,000 U.S. cell sites and becomes a fourth major tenant.

AMT $88B

Dane Bowler Oct 30 3 clicks

CVX Earnings Review

Chevron’s Q3 revenue rose 35% to $65.2 billion and EBITDA 75% to $20.2 billion, while production trailed guidance and refining margins…

CVX $465B

Cestrian Capital Research Oct 30 3 clicks

AstraZeneca (AZN) Q3 FY12/26 Earnings Review

AstraZeneca reported $16.2 billion Q3 revenue, up 7%, as oncology grew 17% and Farxiga fell 25% after US generics.

AZN $270B

Cestrian Capital Research Oct 30 2 clicks

SNY Earnings Review

Sanofi raised FY26 guidance after Q3 sales grew 14.3% at constant currency, led by 34.8% Dupixent growth; vaccines declined 6.6%.

SNY $108B

Cestrian Capital Research Oct 30 1 click

SK hynix: Despite Their Premium To The Korean Shares, The U.S. ADRs Are A Bargain

SK hynix's U.S. ADR trades at a valuation discount despite AI-driven memory demand, with 50% of 2027–2028 capacity under long-term…

SKHY $806B

Adam Schadt Oct 30 2 clicks

T · short

At&t INC

AT&T’s stalled deleveraging and share repurchase case has prompted a bearish turn on the telecom stock.

T $144B

Value Investors Club Aug 3

Microsoft's AI Boom Has A Cost

Microsoft’s Azure grew 48% as AI monetization accelerated, but doubled CapEx, largely for CPUs and GPUs, reduced quarterly free cash flow…

MSFT $3.9T

Yiannis Zourmpanos Oct 31 1 click

Regeneron (REGN) Q3 FY 12/26 Earnings Review

Regeneron’s Q3 revenue rose 36% to $5.1 billion, driven by a 68% jump in Sanofi collaboration revenue, while operating income doubled to…

REGN $84B

Cestrian Capital Research Oct 30 2 clicks

Bloom: Chinese Scandium Supply Route Restarts

Bloom may have reopened imports of scandium-containing components from China to the United States, according to new trade data.

BE $67B

Hunterbrook Oct 30 4 clicks

XOM Q3 FY12/26 Earnings Review - Distribute Rating - No Paywall.

ExxonMobil’s Q3 revenue rose 33% to $113.2 billion as refining earned $9.1 billion, surpassing upstream; the company set 2027 buybacks at…

XOM $771B

Cestrian Capital Research Oct 30 2 clicks

Amazon 3Q’26: Trillion Dollar Talks

Amazon projects AWS growth above 40% through 2028 while funding a $220 billion capex plan with rising debt and an $80 billion equipment…

AMZN $2.6T

MBI Deep Dives Oct 30 3 clicks

TSOH Weekly Roundup (10/30/2026)

Markel spent $315 million repurchasing shares in Q3 as Thrive agreed to buy ADT for $7.6 billion and Hasbro cited rising adult toy demand.

MKL $23B

TSOH Investment Research Oct 30 1 click

Alphabet's Post-Earnings Selloff Is The Best Buying Opportunity In Years

Alphabet's Google Cloud operating income more than tripled to $11.1 billion, while EPS fell 26% on a $2.76 billion SpaceX paper loss.

GOOGL $4T

Rick Orford Oct 30 5 clicks

AMZN Q3 FY12/26 Earnings Review

Amazon reported $201.9 billion Q3 revenue and 39% AWS growth, while $220 billion in 2026 capex drove trailing free cash flow to a $42.4…

AMZN $2.6T

Cestrian Capital Research Oct 30 3 clicks

Earnings Review: $AMZN and $LLY

Amazon’s AWS revenue grew 39% to $46B as capex drove negative FCF; Lilly raised 2026 guidance to $91-92B on GLP-1 volume growth.

AMZN $2.6TLLY $1.3T

Rebound Capital Oct 30 2 clicks

Sunday, November 1, 2026

Trevor Scott on X

Chris Camillo on X

John_Hempton on X

Colin King on X

Chris Camillo on X

kab60 on X

Lee Roach on X

Convequity on X

Investor Letters

Publications we follow

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 67 of 267

X accounts we follow

Investor letters we follow

Sectors